Personal profile

Area of Expertise

Dr. Olivarez runs multiple clinical trials including 28-week degludec combination liraglutide phase 3 study, 26 week degludec combination liraglutide phase 3 study, IBS diarrhea predominate phase 3 drug trials, and opioid-induced constipation phase 3 drug study.

Education/Academic qualification

BA in Economics, Baylor University